Nyxoah SA (NASDAQ:NYXH) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Nyxoah SA (NASDAQ:NYXH) have received an average rating of “Moderate Buy” from the five analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a buy rating and one has given a strong buy rating to the company. The average 12-month target price among analysts that have covered the stock in the last year is $11.6667.

A number of research analysts have weighed in on NYXH shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Nyxoah in a report on Monday, December 29th. Cantor Fitzgerald upgraded Nyxoah to a “strong-buy” rating in a research note on Wednesday. Stifel Nicolaus lowered their price objective on shares of Nyxoah from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday, January 29th. Finally, Piper Sandler reissued an “overweight” rating and issued a $9.00 price objective (down from $12.00) on shares of Nyxoah in a report on Friday, November 14th.

Nyxoah Price Performance

NASDAQ NYXH opened at $3.85 on Thursday. The stock has a market capitalization of $131.10 million, a price-to-earnings ratio of -1.55 and a beta of 1.56. Nyxoah has a 1-year low of $3.74 and a 1-year high of $11.87. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.70 and a quick ratio of 1.41. The business’s fifty day moving average price is $4.67 and its 200-day moving average price is $5.08.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Franklin Resources Inc. increased its position in Nyxoah by 0.9% in the second quarter. Franklin Resources Inc. now owns 294,990 shares of the company’s stock worth $2,207,000 after buying an additional 2,655 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in Nyxoah in the 2nd quarter worth approximately $70,000. Bank of America Corp DE increased its holdings in Nyxoah by 72.4% in the 2nd quarter. Bank of America Corp DE now owns 7,866 shares of the company’s stock worth $59,000 after acquiring an additional 3,303 shares in the last quarter. Shay Capital LLC bought a new stake in Nyxoah during the 2nd quarter worth approximately $374,000. Finally, Rossmore Private Capital lifted its holdings in Nyxoah by 12.6% during the third quarter. Rossmore Private Capital now owns 132,746 shares of the company’s stock valued at $616,000 after purchasing an additional 14,806 shares in the last quarter.

About Nyxoah

Nyxoah SA, headquartered in Mont-Saint-Guibert, Belgium, is a medical technology company focused on neuromodulation therapies for sleep‐disordered breathing. Established in 2018, the company’s primary offering is the Genio® system, a minimally invasive bilateral hypoglossal nerve stimulator designed to treat moderate to severe obstructive sleep apnea (OSA). By electrically stimulating the genioglossus muscle, the device helps maintain airway patency during sleep, reducing apnea events and improving overall sleep quality.

The Genio system comprises a small, implantable stimulator positioned submentally and an external activation unit worn by the patient.